|
[1]
|
Huang CL, Wang YM, Li XW, Ren LL, Zhao JP, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497 − 506. http://dx.doi.org/10.1016/S0140-6736(20)30183-5CrossRef
|
|
[2]
|
Zhao F, Cheng J, Cheng SM, Zhang H, Zhao YL, Zhang CY, et al. The current status and challenges regarding tuberculosis infection control in health care facilities in China. Biomed Environ Sci 2015;28(11):848 − 54. http://dx.doi.org/10.1016/S0895-3988(15)30117-3CrossRef
|
|
[3]
|
World Health Organization. WHO guidelines on tuberculosis infection prevention and control 2019 update. Geneva: World Health Organization; 2019. http://www.doc88.com/p-9807872551083.html.http://www.doc88.com/p-9807872551083.html |
|
[4]
|
World Health Organization. Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level. Geneva: World Health Organization; 2016. https://www.who.int/gpsc/ipc-components/en/.[2020-7-18].https://www.who.int/gpsc/ipc-components/en/ |
|
[5]
|
Gizaw GD, Alemu ZQ, Kibret KT. Assessment of knowledge and practice of health workers towards tuberculosis infection control and associated factors in public health facilities of Addis Ababa, Ethiopia: a cross-sectional study. Arch Public Health 2015;73(1):15. http://dx.doi.org/10.1186/s13690-015-0062-3CrossRef
|
|
[6]
|
Mah MW, Deshpande S, Rothschild ML. Social marketing: a behavior change technology for infection control. Am J Infect Control 2006;34(7):452 − 7. http://dx.doi.org/10.1016/j.ajic.2005.12.015CrossRef
|
|
[7]
|
Wang LX, Cheng SM, He GX, Chen MT. China manual of tuberculosis prevention and control. Beijing: China Union Medical University Press. 2010;p.8-9,33. (In Chinese). |